(Click Picture to See Linked Video)
The health wearable market has exploded over the past 18 months, with companies increasingly focused on having to achieve a balance between fashion and functionality. Core to that mission have been attempts to develop products that minimize interference from the wearable to the user’s daily routines while maximizing the value gained from pertinent metric tracking.
Enter Electrozyme, a San Diego based company that has been developing a temporary skin-applied tattoo that uses an electrochemical sensor platform (epidermal biosensor platform) to track a user’s hydration level, electrolyte count, muscle exertion and risk of heat exhaustion and presents the data in real time, with broad application in military, healthcare, and consumer markets.
There are two core innovations at work here. The first is functional. The Company has developed core IP that enables them to synthesize biochemically-selective electrodes. The second is an innovation in process, in that the company has been able to fabricate these electrodes utilizing high-throughput, low cost printing paradigms on conformal substrates. Combined together, the Company’s sensor platform leverages its proprietary ElectromerTM nanotechnology in order to continuously assess chemical information from the surface of the wearer’s skin.
Currently, the way to monitor physical exertion and related metrics is to track an acid called lactate that is produced during intense physical activity. Traditional methods to track lactate build-up involve a finger prick, so Electrozyme’s noninvasive, real-time tracking solution is changing the landscape entirely. What is unclear at this time is how the company will solve power management issues that are implied by a wearable delivering the functionality that the Company hopes to deliver.
Two very accomplished scientists lead Electrozyme, which bodes well for the IP foundation of the Company. Joshua Windmiller, Electrozyme’s CEO, earned his Ph.D. in Electrical Engineering from UCSD. He was awarded with the prestigious Charles Lee Powell Foundation fellowship and is a Gordon Scholar in engineering leadership. He is the recipient of the internationally-acclaimed Printed Electronics USA 2010 Academic R&D award for his developments in printed bioelectronics. His Co-Founder and Electrozyme’s COO, Jared Tangney, received his Ph.D. in Bioengineering from UCSD and was also a Business Technology Fellow at the Jacobs School of Engineering.
To date, the Company has received funding from angel and strategic investors, including $250,000 from Mark Cuban among others.